According to the CDC, pneumococcal pneumonia causes an estimated 225,000 adult hospitalizations each year in the United States.1Pneumococcal vaccination recommendations have existed since the first pneumococcal vaccine was licensed for use in the United States in 1977.2 Pneumococcal vaccines are the best way to help prevent pneumococcal infections, with older adults being at the highest risk for serious illness and death. Pneumococcal vaccination is underutilized, particularly among adults 19-49 at increased risk for disease with only 16% ever receiving a pneumococcal vaccine in 2024.2 Vaccination coverage is also lower for Black and Hispanic adults who are age 65 and older.3
The current rates of pneumococcal pneumonia vaccination leave a significant number of adults vulnerable to pneumococcal disease.
Adults at Risk for Pneumococcal Pneumonia*:
- Adults 50 years or older
- Adults who have the following underlying medical conditions/risk factors:
- Chronic lung disease including COPD, emphysema and asthma
- Chronic heart, kidney or liver disease
- Smoking cigarettes
- Diabetes
- Weakened immune system
*See the adult immunization schedule for a complete list of risk factors.
American Lung Association Resources:
This content was developed in collaboration between the American Lung Association and Pfizer Inc.
For Patient Education:
Here you will find educational resources to improve patient pneumococcal pneumonia education and vaccination uptake. Save or download the resources below for use in your practice and to improve patient pneumococcal pneumonia education and vaccination uptake.
Increasing Vaccine Confidence
Studies show that when a healthcare provider strongly recommends a vaccination to a patient, immunization rates increase. Never miss an opportunity to vaccinate. Each time a patient visits your practice (through a telemedicine visit or in-person), is an opportunity to assess, identify and educate the patient on routine, recommended vaccinations including pneumococcal pneumonia.
This educational content supported by a grant from Pfizer Inc.
Page last updated: July 29, 2026
